Xiaoting Lv

机构：Fujian Medical University, Shandong University, First Affiliated Hospital of Fujian Medical University, Second Affiliated Hospital of Fujian Medical University

发表论文 72 篇 · 总被引 1107 次 · h-index 21

代表论文

Biocatalysis-mediated MOF-to-prussian blue transformation enabling sensitive detection of NSCLC-associated miRNAs with dual-readout signals (2022 · Biosensors and Bioelectronics · 被引 61)
A review of the mechanism of DDIT4 serve as a mitochondrial related protein in tumor regulation (2021 · Science Progress · 被引 52)
S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism (2025 · Nature Communications · 被引 41)
TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization (2022 · EMBO Reports · 被引 24)
Inhibiting Src-mediated PARP1 tyrosine phosphorylation confers synthetic lethality to PARP1 inhibition in HCC (2021 · Cancer Letters · 被引 19)
CGRP: A New Endogenous Cell Stemness Maintenance Molecule (2022 · Oxidative Medicine and Cellular Longevity · 被引 17)